1. Home
  2. TLX
  3. TLX News

Latest Telix Pharmaceuticals Limited American Depositary Shares (TLX) News on February 23, 2025

TLX

GuruFocus.com

2 days ago

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ...

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
TLX

PR Newswire

3 days ago

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
TLX

GlobeNewswire

10 days ago

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

Illuccix® Approved in the United Kingdom
TLX

GlobeNewswire

10 days ago

Illuccix® Approved in the United Kingdom

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?
TLX

Insider Monkey

11 days ago

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
TLX

PR Newswire

23 days ago

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix Completes Acquisition of RLS (USA) Inc.
TLX

GlobeNewswire

a month ago

Telix Completes Acquisition of RLS (USA) Inc.

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
TLX

PR Newswire

a month ago

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

Illuccix® Receives European Approval
TLX

PR Newswire

a month ago

Illuccix® Receives European Approval

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
TLX

PR Newswire

a month ago

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
TLX

PR Newswire

a month ago

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Scintimun® Commercialization Partnership with Curium Pharma
TLX

PR Newswire

a month ago

Scintimun® Commercialization Partnership with Curium Pharma

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
TLX

PR Newswire

a month ago

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
TLX

PR Newswire

2 months ago

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
TLX

PR Newswire

2 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
TLX

GlobeNewswire

2 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
TLX

GlobeNewswire

2 months ago

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
TLX

PR Newswire

3 months ago

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

Share on Social Networks: